Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Nuclear Medicine and Biology
|
May 15, 2003
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging
H J Rennen, W J Oyen, S A Cain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1988
Interleukin 3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover
A D Whetton, P N Monk, S D Consalvey, et al.
Journal of Virology
|
August 17, 2005
Tetraspanins in viral infections: a fundamental role in viral biology?
F Martin, D M Roth, D A Jans, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
April 9, 1999
The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity
S M Vogen, A M Finch, S K Wadi, et al.
Inflammation
|
June 14, 2001
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes
T M Woodruff, A J Strachan, S D Sanderson, et al.
European Journal of Immunology
|
June 1, 1997
The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization
D Bock, U Martin, S Gärtner, et al.
Epidemiology and Infection
|
May 15, 2001
Risk factors for meningococcal disease in university halls of residence
S J Nelson, A Charlett, H J Orr, et al.
Journal of Virology
|
March 23, 2000
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
A Higginbottom, E R Quinn, C C Kuo, et al.
Archives of Disease in Childhood
|
February 24, 2004
Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk?
K L Davison, N Andrews, J M White, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Nuclear Medicine and Biology
|
May 15, 2003
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging
H J Rennen, W J Oyen, S A Cain, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1988
Interleukin 3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover
A D Whetton, P N Monk, S D Consalvey, et al.
Journal of Virology
|
August 17, 2005
Tetraspanins in viral infections: a fundamental role in viral biology?
F Martin, D M Roth, D A Jans, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
April 9, 1999
The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity
S M Vogen, A M Finch, S K Wadi, et al.
Inflammation
|
June 14, 2001
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes
T M Woodruff, A J Strachan, S D Sanderson, et al.
European Journal of Immunology
|
June 1, 1997
The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization
D Bock, U Martin, S Gärtner, et al.
Epidemiology and Infection
|
May 15, 2001
Risk factors for meningococcal disease in university halls of residence
S J Nelson, A Charlett, H J Orr, et al.
Journal of Virology
|
March 23, 2000
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
A Higginbottom, E R Quinn, C C Kuo, et al.
Archives of Disease in Childhood
|
February 24, 2004
Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk?
K L Davison, N Andrews, J M White, et al.
British Journal of Pharmacology
|
December 22, 1999
Pharmacological characterization of antagonists of the C5a receptor
N J Paczkowski, A M Finch, J B Whitmore, et al.
Page
of 5